cp 115953 has been researched along with quercitrin in 1 studies
| Studies (cp 115953) | Trials (cp 115953) | Recent Studies (post-2010) (cp 115953) | Studies (quercitrin) | Trials (quercitrin) | Recent Studies (post-2010) (quercitrin) |
|---|---|---|---|---|---|
| 20 | 0 | 0 | 348 | 0 | 169 |
| Protein | Taxonomy | cp 115953 (IC50) | quercitrin (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 2.606 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 2.606 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.16 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 1.075 | |
| Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | 10 | |
| Non-structural protein 1 | Dengue virus | 1.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corbett, AH; Osheroff, N; Robinson, MJ | 1 |
1 other study(ies) available for cp 115953 and quercitrin
| Article | Year |
|---|---|
Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II.
Topics: Adenosine Triphosphate; Amsacrine; Animals; Anti-Infective Agents; Antineoplastic Agents; Binding Sites; Cell Nucleus; DNA Topoisomerases, Type II; DNA, Bacterial; Drosophila melanogaster; Escherichia coli; Etoposide; Fluoroquinolones; Genistein; Hydrolysis; Isoflavones; Novobiocin; Plasmids; Quercetin; Quinolones; Topoisomerase II Inhibitors | 1993 |